Among the DEGs, only five genes, CHAC1, SLC7A11, COL4A3, EGR3, and RGS5, which were influenced in NASH but recovered by resmetirom treatment, were further validated by qPCR in the RNA samples used in sequencing. This evidence concerns the gene EGR3 and metabolic dysfunction-associated steatohepatitis.